Guardant Health Statistics
Share Statistics
Guardant Health has 123.56M shares outstanding. The number of shares has increased by 1.51% in one year.
| Shares Outstanding | 123.56M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.43% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 117.85M |
| Failed to Deliver (FTD) Shares | 28 |
| FTD / Avg. Volume | 0% |
Short Selling Information
The latest short interest is 8.25M, so 6.68% of the outstanding shares have been sold short.
| Short Interest | 8.25M |
| Short % of Shares Out | 6.68% |
| Short % of Float | 7% |
| Short Ratio (days to cover) | 4.72 |
Valuation Ratios
The PE ratio is -6.32 and the forward PE ratio is -10.97.
| PE Ratio | -6.32 |
| Forward PE | -10.97 |
| PS Ratio | 5.37 |
| Forward PS | 4.2 |
| PB Ratio | 19.09 |
| P/FCF Ratio | -8.77 |
| PEG Ratio | n/a |
Enterprise Valuation
Guardant Health Inc. has an Enterprise Value (EV) of 3.25B.
| EV / Earnings | -6.78 |
| EV / Sales | 5.76 |
| EV / EBITDA | -7.5 |
| EV / EBIT | -5.75 |
| EV / FCF | -9.41 |
Financial Position
The company has a current ratio of 6.54, with a Debt / Equity ratio of 7.18.
| Current Ratio | 6.54 |
| Quick Ratio | 6.24 |
| Debt / Equity | 7.18 |
| Total Debt / Capitalization | 87.78 |
| Cash Flow / Debt | -0.29 |
| Interest Coverage | -219.06 |
Financial Efficiency
Return on equity (ROE) is -3.02% and return on capital (ROIC) is -37.39%.
| Return on Equity (ROE) | -3.02% |
| Return on Assets (ROA) | -0.27% |
| Return on Capital (ROIC) | -37.39% |
| Revenue Per Employee | 318.98K |
| Profits Per Employee | -271.18K |
| Employee Count | 1.77K |
| Asset Turnover | 0.32 |
| Inventory Turnover | 3.67 |
Taxes
| Income Tax | 685.00K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 30.92% in the last 52 weeks. The beta is 1.11, so Guardant Health 's price volatility has been higher than the market average.
| Beta | 1.11 |
| 52-Week Price Change | 30.92% |
| 50-Day Moving Average | 30.49 |
| 200-Day Moving Average | 26.33 |
| Relative Strength Index (RSI) | 57.19 |
| Average Volume (20 Days) | 1.75M |
Income Statement
In the last 12 months, Guardant Health had revenue of 563.95M and earned -479.45M in profits. Earnings per share was -4.28.
| Revenue | 563.95M |
| Gross Profit | 336.90M |
| Operating Income | -564.73M |
| Net Income | -479.45M |
| EBITDA | -433.31M |
| EBIT | -564.73M |
| Earnings Per Share (EPS) | -4.28 |
Balance Sheet
The company has 1.13B in cash and 1.35B in debt, giving a net cash position of -220.23M.
| Cash & Cash Equivalents | 1.13B |
| Total Debt | 1.35B |
| Net Cash | -220.23M |
| Retained Earnings | -2.14B |
| Total Assets | 1.54B |
| Working Capital | 1.03B |
Cash Flow
In the last 12 months, operating cash flow was -324.98M and capital expenditures -20.49M, giving a free cash flow of -345.46M.
| Operating Cash Flow | -324.98M |
| Capital Expenditures | -20.49M |
| Free Cash Flow | -345.46M |
| FCF Per Share | -3.08 |
Margins
Gross margin is 5.97K%, with operating and profit margins of -10.01K% and -8.50K%.
| Gross Margin | 5.97K% |
| Operating Margin | -10.01K% |
| Pretax Margin | -8.49K% |
| Profit Margin | -8.50K% |
| EBITDA Margin | -76.83% |
| EBIT Margin | -100.14% |
| FCF Margin | -61.26% |
Dividends & Yields
GH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -12.68% |
| FCF Yield | -8.28% |
Analyst Forecast
The average price target for GH is $39, which is 15.6% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39 |
| Price Target Difference | 15.6% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 14 |
Scores
| Altman Z-Score | -0.62 |
| Piotroski F-Score | 4 |